Tislelizumab Shows Promise in Pre Surgical Rectal Cancer
New findings indicate that the drug Tislelizumab significantly boosts tumour response in patients undergoing pre surgical treatment for rectal cancer. This development, highlighted by EMJ, offers a promising advancement in oncology.
Read MoreViagra’s Active Ingredient Shows Cancer-Fighting Potential
Israeli scientists have uncovered promising early research indicating that sildenafil, the active ingredient in the widely known medication Viagra, might possess properties that could impede or even halt the proliferation of cancer cells, igniting a new…
Read More
cfDNA Fragmentomics Shows Promise for Gallbladder Cancer Diagnosis
A new diagnostic approach, cfDNA Fragmentomics, is showing promise for the early detection of gallbladder cancer, a disease often diagnosed at an advanced stage. This noninvasive method analyzes cell free DNA in the blood, offering hope for improved…
Read More